Navigation Links
Veran Medical Technologies Completes Financing Worth More Than $15 Million
Date:3/18/2011

ST LOUIS, March 18, 2011 /PRNewswire/ -- Veran Medical Technologies announced today that it has completed a round of financing worth more than $15M. Participants in the financing included existing investors and a new strategic partner. The proceeds from this financing will be used to commercialize products on the IG4 four-dimensional image guidance platform of technology.

"We are pleased to secure this funding as it will enable us to rapidly commercialize the products we are building and continue to impact patient care in an effort to diagnose and treat cancer earlier," said Jerome Edwards, president and CEO.

About Veran Medical Technologies, Inc.

Veran Medical Technologies is a privately held company led by a team of ex-Medtronic innovators focused on developing the next standard of care for minimally invasive delivery of interventional oncology therapies. Veran has built several clinical products upon its IG4 platform technology, which uses proprietary 4-D registration capabilities for targeting lesions within the human body. The company believes that by enabling minimally invasive, early stage treatments, it can increase patient survival and lower Healthcare Costs significantly. Veran is headquartered in St. Louis, MO.


'/>"/>
SOURCE Veran Medical Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Veran Medical Technologies First SPiN Drive Installation at Duke Medical Center
2. Aegis Analytical Corp. Showcases Discoverant at Inaugural Venture Capital in the Rockies Fall
3. Boveran Diagnostics, Inc. Announces Planned Acquisition of New York-Based Pathology Lab: Sophora Diagnostic Lab, Inc.
4. Investing in Biomedical Innovation
5. Informed Medical Communications and IC Axon Merge Creating a Full Complement of Training and Marketing Services
6. OncoSec Medical Appoints Punit Dhillon as President and CEO
7. Argentum Medical Issues Response to Recent Decision in Litigation With Noble Biomaterials
8. D3 Oncology Solutions Now Includes Via Oncology Pathways for Medical Oncology
9. WARFARIN Study Launched at Overlake Hospital Medical Center to Assess Impact of Genetic Testing in Reducing Hospitalizations and Deaths Caused by Warfarin
10. Sensus Healthcare Announces the Formation of a Medical Advisory Board
11. Chimerix Awarded BARDA Contract for Advanced Development of Broad Spectrum Antiviral CMX001 as Medical Countermeasure Against Smallpox
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2017)... Paramus, New Jersey (PRWEB) , ... September 21, ... ... for highly-regulated pharmaceutical and clinical research sector professionals, has announced the addition of ... CFR Part 11 training - Compliance with Regulation 21 CFR Part 11 ...
(Date:9/21/2017)... ... September 21, 2017 , ... Biorez, ... election of Paul Hermes, Entrepreneur in Residence at Medtronic, Inc., to serve as ... a proprietary, tissue-engineered scaffold for anterior cruciate ligament (ACL) reconstruction that is designed ...
(Date:9/20/2017)... ... 20, 2017 , ... Diversity focused business accelerator, The Refinery , announced ... to uncover the top technology-driven, women-led startups in Boston, MA, New Haven/Hamden, CT, and ... entrepreneurial events going on that week – in Boston, it will be part of ...
(Date:9/20/2017)... East Hanover, N.J. (PRWEB) , ... ... ... Foundation researchers have recently published findings of a study examining the effects ... and individuals with spinal cord injury (SCI). The article, "Neuromechanical adaptations during ...
Breaking Biology Technology:
(Date:8/23/2017)... , Aug. 23, 2017  The general public,s help is being ... microbiome—the bacteria that live in and on the human body –and are ... The Microbiome ... the human microbiome, starting with the gut. The project's goal is to ... Photo credit: IBM ...
(Date:8/15/2017)... LLC , a medical device company focused on improving the safety ... ISO 13485 Certification, the global standard for medical device quality management ... ... for the early detection of IV infiltrations. ... "This is an important milestone for ivWatch, as it validates our ...
(Date:7/20/2017)... , July 20, 2017 Delta (NYSE: DAL ... board any Delta aircraft at Reagan Washington National Airport (DCA). ... Delta launches biometrics to ... Delta,s biometric ... Sky Club is now integrated into the boarding process to allow ...
Breaking Biology News(10 mins):